Will missing deadlines continue the decline in share price. Why does the company continue to issue unrealistic timelines, when they hurt future share prices
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025